在知识产权保护框架下解决艾滋病药品可及性问题研究

Research on the Accessibility of Anti-AIDS Drugs under the Framework of Intellectual Property Protection

与贸易有关的知识产权协议(TRIPS)确立的国际知识产权保护体制和发达国家倡导的药品专利TRIPS-Plus条款的全球推进,限制了发展中国家及最不发达国家对艾滋病药品的获取能力,对公共健康保护产生负面影响。本文基于知识产权视角,从成员国自主选择灵活性条款以及国际合作两个方面探讨解决艾滋病药品的可及性问题的有效途径。

The international intellectual property protection system established by TRIPS and the global promotion of the drug patent TRIPS-Plus clause advocated by developed countries have limited the accessibility of anti-AIDS drugs in developing and undeveloped countries,which has a negative impact on public health.Based on the perspective of intellectual property rights,this paper discusses the effective ways to solve the problem of anti-AIDS drugs accessibility from the two aspects,the selection of flexibility clauses by member states and international cooperation.